Investigation Widens into Cases of Botulism-Like Illness Following Cosmetic Injections
CHICAGO — The Centers for Disease Control and Prevention (CDC) has expanded its investigation into cases of a botulism-like illness after individuals received cosmetic injections, commonly referred to as “botox,” outside of medical settings. Initially, the cases under scrutiny were limited to Illinois and Tennessee. However, the investigation has since broadened after receiving reports of additional cases in nine states, affecting a total of 19 people.
Increasing Concerns
According to the CDC, nine individuals have been hospitalized, with four receiving botulism anti-toxin due to symptoms “consistent with possible spread of toxins.” While no deaths have been reported thus far, the agency emphasizes the importance of using FDA-approved products and receiving cosmetic injections from licensed providers in licensed settings.
Counterfeit Products:
The ongoing investigation, helmed by the CDC, the U.S. Food and Drug Administration, and multiple states, has pointed to a distressing finding – the counterfeit nature of the injection products. The Tennessee Department of Health released a press statement indicating that the administered product was likely counterfeit. Furthermore, it was determined that many injections were given in non-healthcare environments, including private homes and spas, by individuals without proper training or licensure.
The Serious Dangers of Botulism
Botulism, an uncommon yet severe illness caused by toxins released by certain bacteria, attacks the nervous system, resulting in a range of debilitating symptoms. These may include blurry or double vision, droopy eyelids, difficulty breathing, fatigue, slurred speech, hoarse voice, and, if left untreated, muscular paralysis that can prove fatal. The Illinois Department of Public Health highlights that the botulinum bacteria is an ingredient present in Botox and similar cosmetic substances. However, the purified form of botulinum toxin is FDA-approved solely for use by licensed healthcare providers in cosmetic treatments, as stated in a press release from the department.
A Rare Occurrence
Systemic botulism cases resulting from cosmetic or therapeutic injections of botulinum toxin are exceptionally rare, affirms the CDC.
Professional Standards & Recommendations
The CDC investigation has revealed concerning deficiencies in the industry, raising the need for caution. The Illinois Department of Public Health and officials from Tennessee strongly emphasize the significance of seeking cosmetic treatments exclusively from licensed professionals and approved settings to warrant safety. Dr. Sameer Vohra, Director of the Illinois Department of Public Health, stresses that unsanctioned settings pose serious health risks.
Continued Investigation
Though approached by CNN, the FDA declined to comment on the ongoing investigation.
ABC7 Chicago contributed to this report.
The-CNN-Wire & 2024 Cable News Network, Inc., a Time Warner Company. All rights reserved.
